Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury
Open Access
- 19 April 2017
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 18 (1) , 1-14
Abstract
Interleukin 6 (IL-6) is a predictive factor of poor prognosis in patients with acute respiratory distress syndrome (ARDS). However, its acute pulmonary hemodynamic effects and role in lung injury have not been investigated in a clinically relevant murine model of ARDS. We used adult C57Bl6 wild-type (WT) and IL-6 knock-out (IL-6KO) mice. The animals received intravenous recombinant human IL-6 (rHuIL-6) or vehicle followed by intratracheal lipopolysaccharide (LPS) or saline before undergoing low tidal volume mechanical ventilation (MV) for 5 h. Before sacrifice, right ventricular systolic pressure and cardiac output were measured and total pulmonary resistance was calculated. After sacrifice, lung inflammation, edema and injury were assessed with bronchoalveolar lavage (BAL) and histology. In other experiments, right ventricular systolic pressure was recorded during hypoxic challenges in uninjured WT mice pretreated with rHuIL-6 or rHuIL-6 + non-selective nitric oxide synthase inhibitor L-NAME or vehicle. IL-6KO(LPS+MV) mice showed a faster deterioration of lung elastic properties and more severe bronchoalveolar cellular inflammation as compared to WT(LPS+MV). Treatment with rHuIL-6 partially prevented this lung deterioration. Total pulmonary resistance was higher in IL-6KO(LPS+MV) mice and this increase was abolished in rHuIL-6-treated IL-6KO mice. Finally, rHuIL-6 reduced hypoxic pulmonary vasoconstriction in uninjured WT mice, an effect that was abolished by co-treatment with L-NAME. In a double-hit murine model of ARDS, IL-6 deficient mice experienced more severe bronchoalveolar cellular inflammation as compared to wild-type littermates. Furthermore, IL-6 deficiency caused marked acute pulmonary hypertension, which may be, at least partially, due to vasoactive mechanisms. A dysregulation of nitric oxide synthase may account for this observation, a hypothesis that will need to be investigated in future studies.Keywords
Funding Information
- Fonds de Recherche en Santé Respiratoire
- Legs Poix - Chancellerie des Universités de Paris
This publication has 61 references indexed in Scilit:
- Intratracheal IL-6 Protects against Lung Inflammation in Direct, but Not Indirect, Causes of Acute Lung Injury in MicePLOS ONE, 2013
- Role of Caveolin‐1 Expression in the Pathogenesis of Pulmonary Edema in Ventilator‐Induced Lung InjuryPulmonary Circulation, 2012
- Conflicting Physiological and Genomic Cardiopulmonary Effects of Recruitment Maneuvers in Murine Acute Lung InjuryAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Interleukin-6 mediates pulmonary vascular permeability in a two-hit model of ventilator-associated lung injuryExperimental Lung Research, 2011
- Retro-orbital injections in miceLab Animal, 2011
- Pulmonary Vascular Dysfunction Is Associated with Poor Outcomes in Patients with Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Neutrophil-Derived IL-6 Limits Alveolar Barrier Disruption in Experimental Ventilator-Induced Lung InjuryThe Journal of Immunology, 2009
- IL-6 Cytoprotection in Hyperoxic Acute Lung Injury Occurs via Suppressor of Cytokine Signaling-1–Induced Apoptosis Signal–Regulating Kinase-1 DegradationAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in miceRespiratory Research, 2009
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998